| INTRODUC TI ON
Placental breast cancer resistance protein (BCRP, encoded by ABCG2 gene), predominantly located on apical brush-border membrane of the syncytiotrophoblast, plays a critical role in controlling transplacental transfer rates of various drugs. 1 Investigations on placental BCRP regulation are most likely to offer great promise for progress in individualized and safe pharmacotherapy during pregnancy. Currently, data regarding epigenetic regulation of placental BCRP are lacking. As core members of class Ⅰ histone deacetylases (HDACs), HDAC1, 2 and 3 are abundantly expressed in trophoblast cells and involved in an extremely broad spectrum of gene regulation in the placenta. [2] [3] [4] Recent work in tumour cells, [5] [6] [7] along with our previous findings in the placenta, 8 implied that HDAC1/2/3 might play a significant role in placental BCRP regulation. Importantly, given the discovery of dietary bioactive compounds that can affect HDAC1/2/3 expression and activity, 9 it will be possible to clinically manipulate placental BCRP safely and effectively by means of epigenetics during pregnancy. Therefore, we carried out this preliminary study to investigate the effect of HDAC inhibition on placental BCRP expression and to further determine the role of HDAC1/2/3 in the placental BCRP regulation in vitro, which might shed some light on the pathway of placental BCRP regulation from the perspective of epigenetics
| MATERIAL S AND ME THODS
After being authenticated by specific biomarkers (CK7, hPL and hCG positive; HLA-G negative) to confirm its cell identity, 10 
| D ISCUSS I ON
To our knowledge, our study was the first one to elucidate that Representative fluorescent images of BCRP (green staining) were obtained using immunofluorescence microscopy (C). Quantitative fold changes in BCRP expression were analysed using Image J version 1.44 (D). BCRP functionality was measured by the intracellular retention of Hoechst 33342 (5 μg/mL) in the presence or absence of the BCRP-specific inhibitor Ko143 (1 μmol/L). Intracellular fluorescence was analysed by the fluorescence plate reader (E). Data are expressed as Means ± SEM. *P ＜ 0.05, **P ＜ 0.01, ***P ＜ 0.001; asterisk represents differences among siRNA-transfected groups; line represents differences between efflux in absence of Ko143 and in presence of Ko143 or function, aiming to further testify the current data and more importantly, to uncover some regulators besides HDAC1/2/3 involved in this process.
Despite these limitations, we took the first step and made some preliminary exploration of placental BCRP regulation from the perspective of epigenetics in vitro, which was currently lacking in the literature. Obviously, these data obtained from current pilot experiments cannot fully reflect the physiological and biochemical changes in placenta; However, our present findings might expand the limited knowledge with respect to epigenetic regulation of placental BCRP and provide some clues for further studies.
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